摘要
In a recent study published in Cell,Zhang and colleagues provide the first longitudinal study comparing four different COVID-19 vaccines head-to-head for binding and neutralizing antibodies,spike-specific CD4+or CD8+T cells,and spike-and receptorbinding domain(RBD)-specific memory B cells(Fig.1).
基金
funded by the research consortium NATON.The NATON project(grant number 01KX2121)
funded by the Federal Ministry of Education and Research(BMBF)in Germany.
